Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.

Format available


Date: 29 Nov 2018
Presenter: A. Ali, UK
Resources: Presentation
Topics: Central Nervous System Malignancies, Pathology/Molecular Biology, Biological Therapy


Date: 29 Nov 2018
Presenter: M. Weller, CH
Resources: Presentation
Topics: Central Nervous System Malignancies, Pathology/Molecular Biology


Date: 25 Nov 2018
Presenter: Li-Tzong Chen
Topics: Hepatobiliary Cancers, Cancer Biology, Pathology/Molecular Biology, Therapy


BackgroundClinicopathological features and prognosis of wild-type GIST defined as GIST lacking mutations in KIT and PDGFRA genes are unknown. We conducted the panel analysis of wild-type GIST.

Date: 25 Nov 2018
Presenter: Toshiro Nishida
Resources: Abstract, Presentation, Webcast
Topics: GIST, Pathology/Molecular Biology


BackgroundEndometrial carcinoma is the most common malignancy of the female genital tract. Adjuvant chemotherapy sequentially with radiation has shown to improve progression free survival in previous studies.

Date: 24 Nov 2018
Presenter: Zarka Samoon
Resources: Abstract
Topics: Endometrial Cancer, Pathology/Molecular Biology


BackgroundAcute myeloid leukemia (AML) is a heterogeneous disease. Based on cytogenetics findings, AML patients are stratified into three major risk categories: favorable, intermediate and unfavorable....

Date: 24 Nov 2018
Presenter: Zeeshan Ahmed
Resources: Abstract
Topics: Leukaemia, Cancers in Adolescents and Young Adults (AYA), Pathology/Molecular Biology


BackgroundInfiltrating lobular carcinoma (ILC) represents about 10% of breast cancer and rarely shows over-expression of human epidermal growth factor receptor 2 (HER2).

Date: 24 Nov 2018
Presenter: Ga Jing Kee
Resources: Abstract
Topics: Breast Cancer, Pathology/Molecular Biology


BackgroundCurrent molecular risk stratification tests have helped clinicians to optimize chemotherapy for hormone receptor positive, HER2 negative early stage breast cancer patients leading to huge...

Date: 24 Nov 2018
Presenter: Manjiri Bakre
Resources: Abstract
Topics: Bioethics, Legal, and Economic Issues, Personalised/Precision Medicine, Breast Cancer, Pathology/Molecular Biology


BackgroundCurrent guidelines recommend a step-wise screening algorithm for all colorectal carcinomas (CRC), to identify patients with Lynch Syndrome (LS). We investigated the impact of pathologist...

Date: 24 Nov 2018
Presenter: Zoe Loh
Resources: Abstract
Topics: Hereditary Syndromes, Colon and Rectal Cancer, Pathology/Molecular Biology


BackgroundTNM stage is still the only prognostic tool used in clinical practice to treat patients but it fails to accurately predict outcomes. Categorization of locally advanced rectal cancers into...

Date: 24 Nov 2018
Presenter: Jing Zhang
Resources: Abstract
Topics: Colon and Rectal Cancer, Pathology/Molecular Biology